Glenmark Pharma Update by Epic Research

Epic Update Glenmark
Epic Update Glenmark
Epic Update Glenmark

Epic Update Glenmark

Glenmark Pharmaceuticals current portfolio consists of 93 products authorized for distribution in the U.S. marketplace and 71 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.

Real Time News & Trading Trends Keep Liking Epic Research Private Limited

Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300